Shai Mulinari
51 – 60 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden
(
- Contribution to journal › Article
-
Mark
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
(
- Contribution to journal › Article
-
Mark
Disclosure of payments by pharmaceutical companies to healthcare professionals in the United Kingdom: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
(
- Contribution to journal › Article
-
Mark
Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny
(
- Contribution to journal › Letter
-
Mark
Overuse of methylphenidate : an analysis of Swedish pharmacy dispensing data
(
- Contribution to journal › Article
-
Mark
Categorical and anti-categorical approaches to US racial/ethnic groupings: revisiting the National 2009 H1N1 Flu Survey (NHFS)
(
- Contribution to journal › Article
- 2017
-
Mark
Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches
(
- Contribution to journal › Article
-
Mark
Two thirds of Survey Respondents in Southern Sweden used Complementary or Alternative Medicine (CAM) in 2015
(
- Contribution to journal › Article
-
Mark
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews
(
- Contribution to journal › Article
-
Mark
The tyranny of the averages and the indiscriminate use of risk factors in public health : The case of coronary heart disease
(
- Contribution to journal › Article